Suzuki Y, Kawada-Matsuo M, Le MN-T, Eng S, Hisatsune J, Sugai M, Sakaguchi T, Komatsuzawa H. The two-component regulatory systems GraRS and SrrAB mediate Staphylococcus aureus susceptibility to Pep5 produced by clinical isolate of Staphylococcus epidermidis. Appl Environ Microbiol. 2024 Jul 24;90(7):e0030024. doi: 10.1128/aem.00300-24. Epub 2024 Jun 4. PMID: 38832774; PMCID: PMC11267926.
Fujii A, Kawada-Matsuo M, Nguyen-Tra Le M, Masuda K, Tadera K, Suzuki Y, Nishihama S, Hisatsune J, Sugawara Y, Kashiyama S, Shiba H, Aikawa T, Ohge H, Sugai M, Komatsuzawa H. Antibiotic susceptibility and genome analysis of Enterococcus species isolated from inpatients in one hospital with no apparent outbreak of vancomycin-resistant Enterococcus in Japan. Microbiol Immunol. 2024 Aug;68(8):254-266. doi: 10.1111/1348-0421.13155. Epub 2024 Jun 14. PMID: 38873884.
Fujii A, Kawada-Matsuo M, Le MN, Suzuki Y, Nishihama S, Shiba H, Aikawa T, Komatsuzawa H. Comprehensive analysis of bacteriocins produced by clinical enterococcal isolates and their antibacterial activity against Enterococci including VRE. Sci Rep. 2025 Feb 9;15(1):4846. doi: 10.1038/s41598-025-89518-8. PMID: 39924578; PMCID: PMC11808071.
Kawayanagi T, Kawada-Matsuo M, Kusaka S, Yasutomi Y, Suzuki Y, Nishihama S, Le MN, Sugawara Y, Hisatsune J, Kutsuno S, Asakawa M, Takeshita T, Nomura R, Shiba H, Sugai M, Komatsuzawa H. Clinical and genetic analysis of oral and nasal staphylococcus aureus isolates in dental patients. Sci Rep. 2025 Apr 16;15(1):13149. doi: 10.1038/s41598-025-93773-0. PMID: 40240397.